On Wednesday, May 6, 2020, from 12:15 pm - 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2.
During this Town Hall, the FDA will have a presentation of updates on guidance for serology test developers and will also answer technical questions about the development and validation of tests for SARS-CoV-2.
To ensure you are able to participate, please dial in 15 minutes prior to the start of the Town Hall.
No hay comentarios:
Publicar un comentario